Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression

H Wang, Y He, Z Sun, S Ren, M Liu, G Wang… - Journal of …, 2022 - Springer
Major depressive disorder is a highly debilitating psychiatric disorder involving the
dysfunction of different cell types in the brain. Microglia are the predominant resident …

Microbiota–gut–brain axis mechanisms in the complex network of bipolar disorders: potential clinical implications and translational opportunities

MA Ortega, MA Álvarez-Mon, C García-Montero… - Molecular …, 2023 - nature.com
Bipolar disorders (BD) represent a severe leading disabling mental condition worldwide
characterized by episodic and often progressive mood fluctuations with manic and …

Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia

E Connell, G Le Gall, MG Pontifex, S Sami… - Molecular …, 2022 - Springer
A consequence of our progressively ageing global population is the increasing prevalence
of worldwide age-related cognitive decline and dementia. In the absence of effective …

Long-term air pollution, genetic susceptibility, and the risk of depression and anxiety: a prospective study in the UK Biobank cohort

X Gao, M Jiang, N Huang, X Guo… - Environmental Health …, 2023 - ehp.niehs.nih.gov
Background: Depression and anxiety are two mental disorders that are often comorbid.
However, the associations of long-term air pollution exposure with depression and anxiety …

How inflammation affects the brain in depression: a review of functional and structural MRI studies

KM Han, BJ Ham - Journal of clinical neurology (Seoul, Korea), 2021 - pmc.ncbi.nlm.nih.gov
This narrative review discusses how peripheral and central inflammation processes affect
brain function and structure in depression, and reports on recent peripheral inflammatory …

The influence of kynurenine metabolites on neurodegenerative pathologies

S Pathak, R Nadar, S Kim, K Liu… - International Journal of …, 2024 - mdpi.com
As the kynurenine pathway's links to inflammation, the immune system, and neurological
disorders became more apparent, it attracted more and more attention. It is the main …

Tryptophan metabolites in depression: modulation by gut microbiota

I Lukić, S Ivković, M Mitić, M Adžić - Frontiers in behavioral …, 2022 - frontiersin.org
Clinical depression is a multifactorial disorder and one of the leading causes of disability
worldwide. The alterations in tryptophan metabolism such as changes in the levels of …

The impact of C-3 side chain modifications on Kynurenic Acid: a behavioral analysis of its analogs in the Motor Domain

D Martos, B Lőrinczi, I Szatmári, L Vécsei… - International journal of …, 2024 - mdpi.com
The central nervous system (CNS) is the final frontier in drug delivery because of the blood–
brain barrier (BBB), which poses significant barriers to the access of most drugs to their …

Revolutionizing our understanding of Parkinson's disease: Dr. Heinz Reichmann's pioneering research and future research direction

M Tanaka, L Vécsei - Journal of Neural Transmission, 2024 - Springer
Millions of individuals around the world are afflicted with Parkinson's disease (PD), a
prevalent and incapacitating neurodegenerative disorder. Dr. Reichmann, a distinguished …

CSF neopterin, quinolinic acid and kynurenine/tryptophan ratio are biomarkers of active neuroinflammation

J Yan, K Kothur, S Mohammad, J Chung, S Patel… - …, 2023 - thelancet.com
Background Defining the presence of acute and chronic brain inflammation remains a
challenge to clinicians due to the heterogeneity of clinical presentations and aetiologies …